April 27, 2020, Cytodyn releases press statement -

April 27, 2020, Cytodyn releases press statement -

Quote:

---

CytoDyn Submits Completed Biologics License Application (BLA) to the FDA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients,

With the BLA filing for a combination therapy now complete, we are continuing our efforts on commercialization-readiness, as well as advancing leronlimab in the other important therapeutic areas of COVID-19, cancer and immunology. The BLA filing is a monumental achievement for our Company

---

Which destroys the argument about complete or completed having different connotations.

April 30, 2020 - Nader sells shares

May 8, 2020, Cytodyn releases press statement -

Quote:

---

ihe BLA will not be considered completed until the Company submits to the FDA clinical datasets required to address FDA comments it received in March 2020, as described in the
Company’s press releases on May 4 and May 6, 2020. CytoDyn expects to submit these clinical datasets on May 11, 2020.

---

It is black and white. Nader lied on the first press release, then sold shares. After he grabbed the money he corrected the first press release.

But then he continued to obfuscate.

May 15, 2020, Cytodyn issues a press release -

Quote:

---

the Company filed its BLA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients with the FDA on April 27, 2020, and submitted additional FDA requested clinical
datasets on May 11, 2020.

---

Any additional datasets sent were useless garbage.